mrna-4157,pembrolizumab
merck,moderna
['mrna4157', 'melanoma', 'so proud', 'pembro', 'moderna']
so proud of the personalized cancer vaccine team at #moderna! the data presented at #aacr2023 of the phase ii randomized #mrna4157 vaccine + pembrolizumab trial in high-risk adjuvant melanoma are extremely promising. 
Cancer Drug developer. Founder of Wittek Research Foundation for HCM. Culture Vulture. Concerned citizen.